دورية أكاديمية
Effect of bronchodilator therapy on the function of external respiration and lung parenchyma in surgical treatment of patients with non-small cell lung cancer combined with chronic obstructive pulmonary disease ; Влияние бронхолитической терапии на функцию внешнего дыхания и состояние легочной паренхимы при хирургическом лечении больных немелкоклеточным раком легкого в сочетании с хронической обструктивной болезнью легких
| العنوان: | Effect of bronchodilator therapy on the function of external respiration and lung parenchyma in surgical treatment of patients with non-small cell lung cancer combined with chronic obstructive pulmonary disease ; Влияние бронхолитической терапии на функцию внешнего дыхания и состояние легочной паренхимы при хирургическом лечении больных немелкоклеточным раком легкого в сочетании с хронической обструктивной болезнью легких |
|---|---|
| المؤلفون: | S. Yu. Dobner, S. V. Fedosenko, A. Yu. Dobrodeev, N. D. Yarovoy, E. N. Samtsov, А. V. Dubakov, E. A. Starovoitova, О. A. Denisova, N. A. Kirillova, С. Ю. Добнер, С. В. Федосенко, А. Ю. Добродеев, Н. Д. Яровой, Е. Н. Самцов, А. В. Дубаков, Е. А. Старовойтова, О. А. Денисова, Н. А. Кириллова |
| المصدر: | Siberian journal of oncology; Том 22, № 5 (2023); 49-59 ; Сибирский онкологический журнал; Том 22, № 5 (2023); 49-59 ; 2312-3168 ; 1814-4861 |
| بيانات النشر: | Tomsk National Research Medical Сепtеr of the Russian Academy of Sciences |
| سنة النشر: | 2023 |
| المجموعة: | Siberian journal of oncology / Сибирский онкологический журнал |
| مصطلحات موضوعية: | тиотропия бромид, perioperative period, chronic obstructive pulmonary disease, bronchodilator therapy, tiotropium bromide, периоперационный период, хроническая обструктивная болезнь легких, бронхолитическая терапия |
| الوصف: | The purpose of the study was to compare the efficacy of regular prolonged inhalation therapy with tiotropium bromide delivered via the Respimat inhaler and short-acting bronchodilator (SAB) therapy with ipratropium bromide/fenoterol in the perioperative period in patients with non-small cell lung cancer (NSCLC) combined with chronic obstructive pulmonary disease (copd).Material and Methods. The study included 66 patients with Nsclc and copd. The patients received tiotropium bromide, 5 mcg/day (TB group) or a combination of ipratropium bromide/fenoterol 20/50 mcg/dose, 2 doses 4 times a day (SAB group) for 6 weeks before and 6 weeks after surgery. The control group consisted of patients who did not receive bronchodilators before surgery, but they received a combination of ipratropium bromide/fenoterol in the postoperative period. All patients underwent tests of pulmonary function (spirometry, body plethysmography), measurement of lung parenchyma density and emphysematous lung areas (high-resolution computed tomography).Results. After preoperative preparation with use of tB or saB, there was a significant improvement in FEV1, FVC, VC, RV, ITGV, and. RV/TLC ratio relative to baseline. In the tB and sad groups, a significant reduction in the severity of total respiratory resistance (Rtot) compared to that in the control group was observed. According to the assessment of lung density and the volume of emphysematous areas on expiration, the results in the TB group were significantly better than those in the sad and control groups. six weeks after surgery, all patients showed a significant decrease in post-FeV1, post-FVC, and post-VC relative to the preoperative values. Bronchodilator therapy resulted in the reduction in Rtot in all groups; however, better results were achieved in the TB group (86 %) compared to sad group (93 %, p=0.03) and control (101.5 %, p=0.02). After surgical treatment, a decrease in the volume of emphysematous areas on inspiration was observed: the parameters were better in the TB group than in ... |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | application/pdf |
| اللغة: | Russian |
| العلاقة: | https://www.siboncoj.ru/jour/article/view/2760/1158Test; Young R.P., Hopkins R.J., Christmas T., Black P.N., Metcalf P., Gamble G.D. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J. 2009; 34(2): 380–6. doi:10.1183/09031936.00144208.; Kondo R., Yoshida K., Eguchi T., Kobayashi N., Saito G., Hamanaka K., Shiina T., Kurai M. Clinical features of lung cancer in smokers with light and mild chronic obstructive pulmonary disease: a retrospective analysis of Japanese surgical cases. Eur J Cardiothorac Surg. 2011; 40(6): 1439–43. doi:10.1016/j.ejcts.2011.03.017.; Vermaelen K., Brusselle G. Exposing a deadly alliance: novel insights into the biological links between COPD and lung cancer. Pulm Pharmacol Ther. 2013; 26(5): 544–54. doi:10.1016/j.pupt.2013.05.003.; Murakami J., Ueda K., Sano F., Hayashi M., Nishimoto A., Hamano K. Pulmonary emphysema and tumor microenvironment in primary lung cancer. J Surg Res. 2016; 200(2): 690–7. doi:10.1016/j.jss.2015.09.004.; Добнер С.Ю., Федосенко С.В., Родионов Е.О., Яровой Н.Д., Петров В.А., Тузиков С.А., Старовойтова Е.А., Самыкина И.А. Рак легкого у больных ХОБЛ и факторы, ассоциированные со снижением их выживаемости. Бюллетень сибирской медицины. 2022; 21(3): 41–9. doi:10.20538/16820363-2022-3-41-49.; Brunelli A., Kim A.W., Berger K.I., Addrizzo-Harris D.J. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013; 143(5 s): 166–90. doi:10.1378/chest.12-2395. Erratum in: Chest. 2014; 145(2): 437.; Белялова Н.С., Дворниченко В.В., Менг А.А., Моклоков А.В., Лелявин Б.И., Сокольников М.В., Улыбин П.С., Хаматов Р.К. Факторы риска хирургии легких: возраст и респираторная функция. Российский онкологический журнал. 2009; (1): 48–9.; Adcock I.M., Caramori G., Barnes P.J. Chronic obstructive pulmonary disease and lung cancer: new molecular insights. Respiration. 2011; 81(4): 265–84. doi:10.1159/000324601.; Roy E., Rheault J., Pigeon M.A., Ugalde P.A., Racine C., Simard S., Chouinard G., Lippens A., Lacasse Y., Maltais F. Lung cancer resection and postoperative outcomes in COPD: A single-center experience. Chron Respir Dis. 2020; 17. doi:10.1177/1479973120925430.; Venkatesan P. GOLD COPD report: 2023 update. Lancet Resp Med. 2022; 11(1). doi:10.1016/S2213-2600(22)00494-5.; González J., Henschke C.I., Yankelevitz D.F., Seijo L.M., Reeves A.P., Yip R., Xie Y., Chung M., Sánchez-Salcedo P., Alcaide A.B., Campo A., Bertó J., Del Mar Ocón M., Pueyo J., Bastarrika G., de-Torres J.P., Zulueta J.J. Emphysema phenotypes and lung cancer risk. PLoS One. 2019 Jul 25; 14(7). doi:10.1371/journal.pone.0219187.; Akira M., Toyokawa K., Inoue Y., Arai T. Quantitative CT in chronic obstructive pulmonary disease: inspiratory and expiratory assessment. Am J Roentgenol. 2009; 192(1): 267–72. doi:10.2214/AJR.07.3953.; https://www.siboncoj.ru/jour/article/view/2760Test |
| DOI: | 10.21294/1814-4861-2023-22-5-49-59 |
| الإتاحة: | https://doi.org/10.21294/1814-4861-2023-22-5-49-59Test https://doi.org/10.1183/09031936.00144208Test https://doi.org/10.1016/j.ejcts.2011.03.017Test https://doi.org/10.1016/j.pupt.2013.05.003Test https://doi.org/10.1016/j.jss.2015.09.004Test https://doi.org/10.20538/16820363-2022-3-41-49Test https://doi.org/10.1378/chest.12-2395Test https://doi.org/10.1159/000324601Test https://doi.org/10.1177/1479973120925430Test https://doi.org/10.1016/S2213-2600Test(22)00494-5 |
| حقوق: | Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). ; Авторы, публикующие статьи в данном журнале, соглашаются на следующее:Авторы сохраняют за собой автороские права и предоставляют журналу право первой публикации работы, которая по истечении 6 месяцев после публикации автоматически лицензируется на условиях Creative Commons Attribution License , которая позволяет другим распространять данную работу с обязательным сохранением ссылок на авторов оригинальной работы и оригинальную публикацию в этом журнале.Авторы имеют право размещать их работу в сети Интернет (например в институтском хранилище или персональном сайте) до и во время процесса рассмотрения ее данным журналом, так как это может привести к продуктивному обсуждению и большему количеству ссылок на данную работу (См. The Effect of Open Access). |
| رقم الانضمام: | edsbas.19A77188 |
| قاعدة البيانات: | BASE |
| DOI: | 10.21294/1814-4861-2023-22-5-49-59 |
|---|